Sign inJoin waitlistJoin the waitlist

George King

Chief Scientific Officer Director of Research · Boston University Medical Center

Credentials: · · · ·

History

Research · Beth Israel Deaconess Medical Center
Present
Vascular Cell Biology Section · Beth Israel Deaconess Medical Center
Present
Research · University of California Davis Health
Present

Endocrinology, Diabetes, and Metabolism
University of Washington School of Medicine
1978–1980
Health
1975–1978
Duke University School of Medicine
1971–1975

Research

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins
Proceedings of the National Academy of Sciences of the United States of America · 1995 · 1,053 citations
Protein kinase C activation and the development of diabetic complications
Review · Diabetes · 1998 · 990 citations
Activation of protein kinase C isoforms and its impact on diabetic complications
Review · Circulation Research · 2010 · 721 citations

Lloyd Aiello
42 papers · 7 as a resident
CK
C Kahn
26 papers
Jennifer Sun
22 papers
Zhiheng He
16 papers · 2 as a resident
WF
Ward Fickweiler
13 papers
JC
Jerry Cavallerano
6 papers
RK
Ronald Klein
6 papers
WH
William Hsu
6 papers
GW
Gordon Weir
5 papers
Tanvi Chokshi
5 papers
TG
Thomas Gardner
5 papers
EC
Eva Chou
4 papers · 1 as a resident

Grants

Characterization of Risk Factors for Excessive Cardiovascular Diseases (CVD) from Circulating and Cardiovascular Tissues of People with Well-Controlled Chronic Type 1 Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $2.9M · Joslin Diabetes Center
2024–2027
Diabetes Research Center
National Institute of Diabetes and Digestive and Kidney Diseases · P30
Contact PI · $22.1M · Joslin Diabetes Center
1997–2027
Characterization of Cardiovascular Diseases (CVD) in People with Long Duration Type 1 Diabetes
National Heart, Lung, and Blood Institute · R01
Contact PI · $3.2M · Joslin Diabetes Center
2021–2025
Characterization of Retinoid-Binding Protein 3 (RBP3): A Protective Factor Against Diabetic Retinopathy Identified in People with Extreme Diabetes Duration
National Eye Institute · R01
Contact PI · $3.1M · Joslin Diabetes Center
2016–2025

Clinical trials

Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
Principal investigator · Unknown
Joslin Diabetes Center
2022–2024
Oral Hypoglycemic Therapy for Monogenic Variant Carriers of the Joslin Medalist Study
Principal investigator · Completed · Phase 2, Phase 3
Joslin Diabetes Center
2021–2024
Changes in Inflammatory State in Asian Americans Changing From Traditional Asian Diets to American Diet - a Pilot Study
Principal investigator · Completed
Joslin Diabetes Center
2005–2014